![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CCP110 |
Gene summary for CCP110 |
![]() |
Gene information | Species | Human | Gene symbol | CCP110 | Gene ID | 9738 |
Gene name | centriolar coiled-coil protein 110 | |
Gene Alias | CP110 | |
Cytomap | 16p12.3 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | O43303 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9738 | CCP110 | LZE4T | Human | Esophagus | ESCC | 2.28e-07 | 1.75e-01 | 0.0811 |
9738 | CCP110 | LZE7T | Human | Esophagus | ESCC | 5.15e-03 | 2.81e-01 | 0.0667 |
9738 | CCP110 | LZE24T | Human | Esophagus | ESCC | 5.19e-04 | 1.48e-01 | 0.0596 |
9738 | CCP110 | P1T-E | Human | Esophagus | ESCC | 2.49e-03 | 1.85e-01 | 0.0875 |
9738 | CCP110 | P2T-E | Human | Esophagus | ESCC | 2.04e-33 | 6.74e-01 | 0.1177 |
9738 | CCP110 | P4T-E | Human | Esophagus | ESCC | 9.89e-08 | 1.46e-01 | 0.1323 |
9738 | CCP110 | P5T-E | Human | Esophagus | ESCC | 4.10e-07 | 6.31e-02 | 0.1327 |
9738 | CCP110 | P8T-E | Human | Esophagus | ESCC | 5.78e-14 | 2.14e-01 | 0.0889 |
9738 | CCP110 | P10T-E | Human | Esophagus | ESCC | 1.70e-13 | 1.33e-01 | 0.116 |
9738 | CCP110 | P11T-E | Human | Esophagus | ESCC | 3.75e-05 | 1.55e-01 | 0.1426 |
9738 | CCP110 | P12T-E | Human | Esophagus | ESCC | 2.26e-13 | 2.20e-01 | 0.1122 |
9738 | CCP110 | P15T-E | Human | Esophagus | ESCC | 4.31e-11 | 2.37e-01 | 0.1149 |
9738 | CCP110 | P16T-E | Human | Esophagus | ESCC | 1.59e-21 | 4.05e-01 | 0.1153 |
9738 | CCP110 | P20T-E | Human | Esophagus | ESCC | 6.03e-06 | 1.34e-01 | 0.1124 |
9738 | CCP110 | P21T-E | Human | Esophagus | ESCC | 1.42e-12 | 1.39e-01 | 0.1617 |
9738 | CCP110 | P22T-E | Human | Esophagus | ESCC | 1.83e-03 | 9.49e-02 | 0.1236 |
9738 | CCP110 | P23T-E | Human | Esophagus | ESCC | 1.05e-06 | 1.84e-01 | 0.108 |
9738 | CCP110 | P24T-E | Human | Esophagus | ESCC | 1.97e-06 | 7.55e-02 | 0.1287 |
9738 | CCP110 | P26T-E | Human | Esophagus | ESCC | 6.50e-12 | 2.19e-01 | 0.1276 |
9738 | CCP110 | P27T-E | Human | Esophagus | ESCC | 1.65e-08 | 1.47e-01 | 0.1055 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00457865 | Esophagus | ESCC | negative regulation of cell cycle | 236/8552 | 385/18723 | 3.62e-10 | 9.93e-09 | 236 |
GO:0010639110 | Esophagus | ESCC | negative regulation of organelle organization | 215/8552 | 348/18723 | 8.20e-10 | 2.01e-08 | 215 |
GO:000091016 | Esophagus | ESCC | cytokinesis | 115/8552 | 173/18723 | 2.48e-08 | 4.68e-07 | 115 |
GO:00109484 | Esophagus | ESCC | negative regulation of cell cycle process | 177/8552 | 294/18723 | 3.26e-07 | 4.59e-06 | 177 |
GO:190211514 | Esophagus | ESCC | regulation of organelle assembly | 116/8552 | 186/18723 | 3.15e-06 | 3.53e-05 | 116 |
GO:00070982 | Esophagus | ESCC | centrosome cycle | 85/8552 | 130/18723 | 4.41e-06 | 4.69e-05 | 85 |
GO:00310233 | Esophagus | ESCC | microtubule organizing center organization | 92/8552 | 143/18723 | 5.04e-06 | 5.31e-05 | 92 |
GO:003134616 | Esophagus | ESCC | positive regulation of cell projection organization | 201/8552 | 353/18723 | 1.19e-05 | 1.11e-04 | 201 |
GO:006049118 | Esophagus | ESCC | regulation of cell projection assembly | 110/8552 | 188/18723 | 2.60e-04 | 1.58e-03 | 110 |
GO:012003218 | Esophagus | ESCC | regulation of plasma membrane bounded cell projection assembly | 108/8552 | 186/18723 | 4.37e-04 | 2.46e-03 | 108 |
GO:01200347 | Esophagus | ESCC | positive regulation of plasma membrane bounded cell projection assembly | 64/8552 | 105/18723 | 1.15e-03 | 5.70e-03 | 64 |
GO:00324653 | Esophagus | ESCC | regulation of cytokinesis | 57/8552 | 92/18723 | 1.20e-03 | 5.88e-03 | 57 |
GO:190211611 | Esophagus | ESCC | negative regulation of organelle assembly | 28/8552 | 41/18723 | 2.88e-03 | 1.21e-02 | 28 |
GO:19021174 | Esophagus | ESCC | positive regulation of organelle assembly | 42/8552 | 67/18723 | 3.72e-03 | 1.52e-02 | 42 |
GO:00513025 | Esophagus | ESCC | regulation of cell division | 97/8552 | 177/18723 | 8.93e-03 | 3.12e-02 | 97 |
GO:001063912 | Liver | HCC | negative regulation of organelle organization | 204/7958 | 348/18723 | 7.67e-10 | 2.37e-08 | 204 |
GO:003134611 | Liver | HCC | positive regulation of cell projection organization | 193/7958 | 353/18723 | 2.28e-06 | 3.08e-05 | 193 |
GO:19021151 | Liver | HCC | regulation of organelle assembly | 110/7958 | 186/18723 | 3.30e-06 | 4.34e-05 | 110 |
GO:0045786 | Liver | HCC | negative regulation of cell cycle | 204/7958 | 385/18723 | 1.84e-05 | 1.99e-04 | 204 |
GO:000091011 | Liver | HCC | cytokinesis | 100/7958 | 173/18723 | 3.38e-05 | 3.39e-04 | 100 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CCP110 | SNV | Missense_Mutation | rs370713605 | c.1298N>T | p.Ala433Val | p.A433V | O43303 | protein_coding | tolerated(0.25) | benign(0.09) | TCGA-A6-6654-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
CCP110 | SNV | Missense_Mutation | rs142274455 | c.2669N>A | p.Arg890Gln | p.R890Q | O43303 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | rs781615627 | c.1471N>A | p.Ala491Thr | p.A491T | O43303 | protein_coding | tolerated(0.52) | benign(0.001) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | rs567612351 | c.1130G>A | p.Arg377Gln | p.R377Q | O43303 | protein_coding | tolerated(0.05) | probably_damaging(0.999) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | c.158N>T | p.Arg53Ile | p.R53I | O43303 | protein_coding | deleterious(0) | possibly_damaging(0.862) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
CCP110 | SNV | Missense_Mutation | rs146335974 | c.1136G>A | p.Arg379His | p.R379H | O43303 | protein_coding | tolerated(0.13) | benign(0.007) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | rs746844150 | c.1990G>A | p.Ala664Thr | p.A664T | O43303 | protein_coding | tolerated(0.05) | possibly_damaging(0.752) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | novel | c.562N>G | p.Pro188Ala | p.P188A | O43303 | protein_coding | tolerated(0.15) | benign(0.015) | TCGA-AM-5820-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CCP110 | SNV | Missense_Mutation | novel | c.2077A>C | p.Lys693Gln | p.K693Q | O43303 | protein_coding | tolerated(0.06) | probably_damaging(0.944) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
CCP110 | SNV | Missense_Mutation | c.295G>T | p.Asp99Tyr | p.D99Y | O43303 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |